eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » GlySure Ltd - Comment

GlySure Ltd - Comment

Document ID: FDA-2012-N-0377-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: July 23 2012, at 12:00 AM Eastern Daylight Time
Date Posted: August 9 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: May 21 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: July 23 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 810ab120
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

GlySure comment re FDA public meeting

Title:
GlySure comment re FDA public meeting

View Attachment: View as format pdf

Related Comments

   
Total: 5
HemoCleanse, Inc. - Comment
Public Submission    Posted: 06/15/2012     ID: FDA-2012-N-0377-0002

Jul 23,2012 11:59 PM ET
American Association for Clinical Chemistry - Comment
Public Submission    Posted: 07/03/2012     ID: FDA-2012-N-0377-0003

Jul 23,2012 11:59 PM ET
James S. Krinsley - Comment
Public Submission    Posted: 07/03/2012     ID: FDA-2012-N-0377-0004

Jul 23,2012 11:59 PM ET
American Association of Clinical Endocrinologists (AACE) - Comment
Public Submission    Posted: 08/09/2012     ID: FDA-2012-N-0377-0005

Jul 23,2012 11:59 PM ET
GlySure Ltd - Comment
Public Submission    Posted: 08/09/2012     ID: FDA-2012-N-0377-0006

Jul 23,2012 11:59 PM ET